Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Giuseppe V. Masucci"'
Autor:
Bernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, Florence Marliot, Carlo Bifulco, Jiun-Kae Jack Lee, Inti Zlobec, Tilman T. Rau, Martin D. Berger, Iris D. Nagtegaal, Elisa Vink-Börger, Arndt Hartmann, Carol I. Geppert, Julie Kolwelter, Susanne Merkel, Robert Grützmann, Marc Van den Eynde, Anne Jouret-Mourin, Alex Kartheuser, Daniel Léonard, Christophe Remue, Julia Wang, Prashant Bavi, Michael H. A. Roehrl, Pamela S. Ohashi, Linh T. Nguyen, SeongJun Han, Heather L. MacGregor, Sara Hafezi-Bakhtiari, Bradly G. Wouters, Giuseppe V. Masucci, Emilia K. Andersson, Eva Zavadova, Michal Vocka, Jan Spacek, Lubos Petruzelka, Bohuslav Konopasek, Pavel Dundr, Helena Skalova, Kristyna Nemejcova, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Gennaro Ciliberto, Michele Maio, Luigi Laghi, Fabio Grizzi, Tessa Fredriksen, Bénédicte Buttard, Lucie Lafontaine, Pauline Maby, Amine Majdi, Assia Hijazi, Carine El Sissy, Amos Kirilovsky, Anne Berger, Christine Lagorce, Christopher Paustian, Carmen Ballesteros-Merino, Jeroen Dijkstra, Carlijn van de Water, Shannon van Lent-van Vliet, Nikki Knijn, Ana-Maria Mușină, Dragos-Viorel Scripcariu, Boryana Popivanova, Mingli Xu, Tomonobu Fujita, Shoichi Hazama, Nobuaki Suzuki, Hiroaki Nagano, Kiyotaka Okuno, Toshihiko Torigoe, Noriyuki Sato, Tomohisa Furuhata, Ichiro Takemasa, Prabhu Patel, Hemangini H. Vora, Birva Shah, Jayendrakumar B. Patel, Kruti N. Rajvik, Shashank J. Pandya, Shilin N. Shukla, Yili Wang, Guanjun Zhang, Yutaka Kawakami, Francesco M. Marincola, Paolo A. Ascierto, Bernard A. Fox, Franck Pagès, Jérôme Galon
Publikováno v:
Cancers, Vol 15, Iss 2, p 418 (2023)
Background: The prognostic value of Immunoscore was evaluated in Stage II/III colon cancer (CC) patients, but it remains unclear in Stage I/II, and in early-stage subgroups at risk. An international Society for Immunotherapy of Cancer (SITC) study ev
Externí odkaz:
https://doaj.org/article/c23a558bb6574ff7a9c3c43460cfaba0
Autor:
Bernhard Mlecnik, Toshihiko Torigoe, Gabriela Bindea, Boryana Popivanova, Mingli Xu, Tomonobu Fujita, Shoichi Hazama, Nobuaki Suzuki, Hiroaki Nagano, Kiyotaka Okuno, Yoshihiko Hirohashi, Tomohisa Furuhata, Ichiro Takemasa, Prabhudas Patel, Hemangini Vora, Birva Shah, Jayendrakumar B. Patel, Kruti N. Rajvik, Shashank J. Pandya, Shilin N. Shukla, Yili Wang, Guanjun Zhang, Takayuki Yoshino, Hiroya Taniguchi, Carlo Bifulco, Alessandro Lugli, Jiun-Kae Jack Lee, Inti Zlobec, Tilman T. Rau, Martin D. Berger, Iris D. Nagtegaal, Elisa Vink-Börger, Arndt Hartmann, Carol I. Geppert, Julie Kolwelter, Susanne Merkel, Robert Grützmann, Marc Van den Eynde, Anne Jouret-Mourin, Alex Kartheuser, Daniel Léonard, Christophe Remue, Julia Wang, Prashant Bavi, Michael H. A. Roehrl, Pamela S. Ohashi, Linh T. Nguyen, SeongJun Han, Heather L. MacGregor, Sara Hafezi-Bakhtiari, Bradly G. Wouters, Giuseppe V. Masucci, Emilia Andersson, Eva Zavadova, Michal Vocka, Jan Spacek, Lubos Petruzelka, Bohuslav Konopasek, Pavel Dundr, Helena Skalova, Kristyna Nemejcova, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Gennaro Ciliberto, Michele Maio, Luigi Laghi, Fabio Grizzi, Florence Marliot, Tessa Fredriksen, Bénédicte Buttard, Lucie Lafontaine, Pauline Maby, Amine Majdi, Assia Hijazi, Carine El Sissy, Amos Kirilovsky, Anne Berger, Christine Lagorce, Christopher Paustian, Carmen Ballesteros-Merino, Jeroen Dijkstra, Carlijn Van de Water, Shannon van Lent-van Vliet, Nikki Knijn, Ana-Maria Mușină, Dragos-Viorel Scripcariu, Francesco M. Marincola, Paolo A. Ascierto, Bernard A. Fox, Franck Pagès, Yutaka Kawakami, Jérôme Galon
Publikováno v:
Cancers, Vol 14, Iss 18, p 4346 (2022)
BACKGROUND: In this study, we evaluated the prognostic value of Immunoscore in patients with stage I–III colon cancer (CC) in the Asian population. These patients were originally included in an international study led by the Society for Immunothera
Externí odkaz:
https://doaj.org/article/70d0d8fd94d34e7c9e02ee65d53aa94e
Autor:
Giuseppe V. Masucci, Alessandra Cesano, Alexander Eggermont, Bernard A. Fox, Ena Wang, Francesco M. Marincola, Gennaro Ciliberto, Kevin Dobbin, Igor Puzanov, Janis Taube, Jennifer Wargo, Lisa H. Butterfield, Lisa Villabona, Magdalena Thurin, Michael A. Postow, Paul M. Sondel, Sandra Demaria, Sanjiv Agarwala, Paolo A. Ascierto
Publikováno v:
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-10 (2017)
Abstract Immunotherapies have emerged as one of the most promising approaches to treat patients with cancer. Recently, the entire medical oncology field has been revolutionized by the introduction of immune checkpoints inhibitors. Despite success in
Externí odkaz:
https://doaj.org/article/c05028c2cdee4748b3c4d55fdebe136f
Autor:
Gabriele Madonna, Giuseppe V. Masucci, Mariaelena Capone, Domenico Mallardo, Antonio Maria Grimaldi, Ester Simeone, Vito Vanella, Lucia Festino, Marco Palla, Luigi Scarpato, Marilena Tuffanelli, Grazia D'angelo, Lisa Villabona, Isabelle Krakowski, Hanna Eriksson, Felipe Simao, Rolf Lewensohn, Paolo Antonio Ascierto
Publikováno v:
Cancers, Vol 13, Iss 16, p 4164 (2021)
The real-life application of immune checkpoint inhibitors (ICIs) may yield different outcomes compared to the benefit presented in clinical trials. For this reason, there is a need to define the group of patients that may benefit from treatment. We r
Externí odkaz:
https://doaj.org/article/e2ced8cceff045ae801eb065539ad35a
Autor:
Hannah Björn Andtback, Viveca Björnhagen-Säfwenberg, Hao Shi, Weng-Onn Lui, Giuseppe V. Masucci, Lisa Villabona
Publikováno v:
Cancers, Vol 13, Iss 2, p 265 (2021)
Merkel cell carcinoma (MCC) is a rare and aggressive skin cancer where Merkel cell Polyomavirus (MCPyV) contributes to the pathogenesis. In an adjuvant setting, radiotherapy (RT) is believed to give a survival benefit. The prognostic impact of sex re
Externí odkaz:
https://doaj.org/article/ef3ba6aa0cbf40bebf7fb160a7e34512
Autor:
Jenny Zhang, Alessandra Cesano, Lisa H. Butterfield, Giuseppe V. Masucci, Rachael Hawtin, Ilan Kirsch, Sylvia Janetzki, Kevin K. Dobbin, John Alvarez, Paul B. Robbins, Senthamil R. Selvan, Howard Z. Streicher, Magdalena Thurin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 4, Iss 1 (2016)
There is growing recognition that immunotherapy is likely to significantly improve health outcomes for cancer patients in the coming years. Currently, while a subset of patients experience substantial clinical benefit in response to different immunot
Externí odkaz:
https://doaj.org/article/748ae8e988824512bc03a5774ee55e31
Autor:
Jenny Zhang, Alessandra Cesano, Lisa H. Butterfield, Giuseppe V. Masucci, Rachael Hawtin, Ilan Kirsch, Sylvia Janetzki, Kevin K. Dobbin, John Alvarez, Paul B. Robbins, Senthamil R. Selvan, Howard Z. Streicher, Magdalena Thurin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 4, Iss 1 (2016)
Immunotherapies have emerged as one of the most promising approaches to treat patients with cancer. Recently, there have been many clinical successes using checkpoint receptor blockade, including T cell inhibitory receptors such as cytotoxic T-lympho
Externí odkaz:
https://doaj.org/article/4a82936ee76d4634b39c83d24e2dece9
Autor:
Rolf Kiessling, Giuseppe V. Masucci, Johan Hansson, Maria Nyström, Yumeng Mao, Giusy Gentilcore, Isabel Poschke, Yago Pico de Coaña
PDF file - 75K, Supplementary figure 1 depicts the absolute lymphocyte counts in patients during ipilimumab treatment. Supplementary figure 2 depicts the correlation analysis of different dellular populations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b8188e28d9991f062ba7222d72e39a6
https://doi.org/10.1158/2326-6066.22536590.v1
https://doi.org/10.1158/2326-6066.22536590.v1
Autor:
Rolf Kiessling, Giuseppe V. Masucci, Johan Hansson, Maria Nyström, Yumeng Mao, Giusy Gentilcore, Isabel Poschke, Yago Pico de Coaña
Blocking the immune checkpoint molecule CTL antigen-4 (CTLA-4) with ipilimumab has proven to induce long-lasting clinical responses in patients with metastatic melanoma. To study the early response that takes place after CTLA-4 blockade, peripheral b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ea96008bda81e6b270e897a9de1cf25d
https://doi.org/10.1158/2326-6066.c.6548177.v1
https://doi.org/10.1158/2326-6066.c.6548177.v1
Autor:
Rolf Kiessling, Giuseppe V. Masucci, Johan Hansson, Maria Nyström, Yumeng Mao, Giusy Gentilcore, Isabel Poschke, Yago Pico de Coaña
PDF file - 51K, These tables show the additional untreated melanoma patients and the antibodies used in flow cytometry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44d714205417247a200f5d1e7f65479f
https://doi.org/10.1158/2326-6066.22536587
https://doi.org/10.1158/2326-6066.22536587